Business & regional news

The renewed partnership builds on over 30 years of collaboration

Medtronic expands its cardiac surgical and respiratory innovation portfolio with the launch of the VitalFlow ECMO System

IRCAD North America is a first-of-its-kind education and training destination in the U.S.

Customers are being asked to remove the affected devices from use and replace with an alternate means of ventilation

Large, international registry designed to expand real-world data for Symplicity blood pressure procedure for uncontrolled hypertension

Minimally invasive laser technology now with enhanced capital system improvements, offering new user interface, workflow efficiencies, and upgrade capabilities

Regulatory review process to give patients better access to innovation through expedited development, assessment, and review of investigational Nellcor™ technology

Medtronic, a global leader in healthcare technology, is proud to announce that it has been honored with the 2025 MedTech Breakthrough Award for 'Best Overall Medical Device Solution' for its...

Medtronic, a global leader in healthcare technology, announced today that it has received CE (Conformité Européenne) Mark approval for several expanded indications for the treatment of coronary...

The Medtronic TAVI indication builds upon commitment to provide best in class patient outcomes today and enabling lifetime management solutions for the future

Installed for the first time in Korea at Seoul National University Hospital… Treatment, research, and education using Hugo to be fully launched in Korea Hugo RAS system expected to be utilized...

Collaboration introduces the Dragonfly™* technology to U.S. market, designed to enhance stone clearance, enable larger biopsy samples, and improve precision in biliary and pancreatic duct procedures

Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease

With its advanced multi-beat hemodynamic algorithm, the Argos™ monitor expands the parameters in the Medtronic perioperative portfolio

New investigational energy waveforms created specifically to target ventricular arrhythmias

Ventricular arrhythmia research will provide important clinical evidence using a new technology for patient population in need of new treatment options

Medtronic Smart MDI system includes unique early notification feature for missed meal boluses and high glucose that enables users to bolus on time. Consistent response to these notifications was associated with Time in Range of 67% and 71%, respectively.

Company honored for its pulsed field ablation technologies to treat atrial fibrillation

Annual recognition honors organizations committed to business integrity through robust ethics, compliance, and governance programs

Data from the largest study comparing drug-coated balloons presented as a late-breaking clinical trial at Cardiovascular Research Technologies 2025